Understanding Chinese Pharmacopoeia (ChP) 2020

Background

The Pharmacopoeia of the People\’s Republic of China (Chinese Pharmacopoeia, or ChP) is China\’s official collection of standards for drug development, production, sales, utilization, supervision, and control. ChP is updated by the Chinese Pharmacopoeia Commission every five years. The latest version is the ChP 2020, of which the API & excipient standards are listed in BaiPharm Database. In China, all drugs shall comply with the ChP standards to obtain marketing authorization. Therefore, ChemLinked BaiPharm Portal holds this webinar to help drug applicants understand and meet the ChP standards.

1. China National Drug Standard System

2. Content of Chinese Pharmacopoeia (ChP) 20203. How to Get Access to API & Excipient Standards of ChP 2020

Schedule

Date	Time (GMT +8)	World Clock	Language
2022-06-15	21:00 ~ 22:00	London: 14:00-15:00 (BST) New York: 9:00-10:00 (EDT)	English

Speakers

Grace Wang

ChemLinked Regulatory Analyst

Grace Wang is a regulatory analyst and editor specializing in pharmaceutical regulations and market trends. She provides news and insights to help international pharma companies with market access in China. Her areas of focus include DMF filing, new drug application, pharmacovigilance, and volume-based procurement policy.

Contact Us

If you have any questions about this webinar, please contact us：

Tel: +86 (0)571 8710 3829

Email：contact@chemlinked.com